Aventiclav 12.5 mg Tablet is a Health Canada–registered veterinary drug (DIN 02394324) held by Norbrook Laboratories Ltd., containing Clavulanic Acid (Clavulanate Potassium). Health Canada lists its status as Dormant (status date 26 Jul 2022).
Health Canada registration
| DIN | 02394324 |
|---|---|
| Brand name | Aventiclav |
| Active ingredient | Clavulanic Acid (Clavulanate Potassium) |
| Strength | 12.5 mg |
| Dosage form | Tablet |
| Route | Oral |
| Company | Norbrook Laboratories Ltd. |
| Status | Dormant — 26 Jul 2022 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Regulator price references for Clavulanic Acid (Clavulanate Potassium)
Published list or reimbursement prices for Clavulanic Acid (Clavulanate Potassium) presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Canada | Clavulin-125 F | 31.25mg/5ml | 125 mg -31,25 mg/5 Susp. Orale per unit | 0.10 CAD | reimbursement | Provincial formulary QC | 2026-09-24 |
| Canada | Jamp Amoxi Clav Powder for | 28.5mg/5ml | 200mg-28.5mg/5ml Suspension per unit | 0.11 CAD | reimbursement | Provincial formulary NL | 2026-09-24 |
| Canada | Clavulin 200 Powder for | 28.5mg/5ml | 200mg-28.5mg/5ml Suspension per unit | 0.20 CAD | reimbursement | Provincial formulary NL | 2026-09-24 |
| Canada | Apo-Amoxi Clav | 125mg | 250/125 mg Tablet per unit | 0.27 CAD | reimbursement | Provincial formulary NL | 2026-09-24 |
| Canada | Clavulin 250 F Oral | 62.5mg/5ml | 250mg/62.5mg per 5ml Suspension per unit | 0.29 CAD | reimbursement | Provincial formulary NL | 2026-09-24 |
| Canada | Pro-Amoxi Clav | 125mg | 500 mg -125 mg Co. per unit | 0.38 CAD | reimbursement | Provincial formulary QC | 2026-09-24 |
| Canada | Sandoz Amoxi-Clav | 125mg | 500/125 mg Tablet per unit | 0.41 CAD | reimbursement | Provincial formulary NL | 2026-09-24 |
| Canada | Auro-Amoxiclav | 125mg | 500/125 mg Tablet per unit | 0.41 CAD | reimbursement | Provincial formulary NL | 2026-09-24 |
| Canada | Jamp Amoxi Clav | 125mg | 500/125 mg Tablet per unit | 0.41 CAD | reimbursement | Provincial formulary NL | 2026-09-24 |
| Canada | Pro-Amoxi Clav | 125mg | 875 mg -125 mg Co. per unit | 0.56 CAD | reimbursement | Provincial formulary QC | 2026-09-24 |
| Canada | Sandoz Amoxi-Clav | 125mg | 875/125 mg Tablet per unit | 0.61 CAD | reimbursement | Provincial formulary NL | 2026-09-24 |
| Canada | Clavulin 875 | 125mg | 875/125 mg Tablet per unit | 3.00 CAD | reimbursement | Provincial formulary NL | 2026-09-24 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Aventiclav (DIN 02394324) marketed in Canada?
No. Health Canada lists DIN 02394324 as Dormant as of 26 Jul 2022.
Who holds the Canadian licence for this product?
Norbrook Laboratories Ltd. is the company of record in the Health Canada Drug Product Database.
Is the same medicine registered outside Canada?
No same-molecule registration has been matched in the 56 national registries Nexara Health tracks. Contact us to check manually.
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02394324, status date 2022-07-26; price sources: Provincial formulary NL, Provincial formulary QC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02394324, status date 2022-07-26; price sources: Provincial formulary NL, Provincial formulary QC.
Health Canada Drug Product Database (DPD), DIN 02394324, status date 2022-07-26; price sources: Provincial formulary NL, Provincial formulary QC. Last reviewed 2026-09-29. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.